You just read:

EMA Accepts Licence Extension Application For Use Of Eisai's Adjunctive Treatment Zonegran® (zonisamide) In Children With Partial Onset Epilepsy

News provided by

Eisai Europe Limited

11 Jul, 2012, 00:01 BST